527 related articles for article (PubMed ID: 19800115)
21. Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells.
Slowing I; Trewyn BG; Lin VS
J Am Chem Soc; 2006 Nov; 128(46):14792-3. PubMed ID: 17105274
[TBL] [Abstract][Full Text] [Related]
22. Room-temperature preparation and characterization of poly (ethylene glycol)-coated silica nanoparticles for biomedical applications.
Xu H; Yan F; Monson EE; Kopelman R
J Biomed Mater Res A; 2003 Sep; 66(4):870-9. PubMed ID: 12926040
[TBL] [Abstract][Full Text] [Related]
23. Behavior of silica particles introduced into an isolated rat heart as potential drug carriers.
Borak B; Arkowski J; Skrzypiec M; Ziółkowski P; Krajewska B; Wawrzyńska M; Grotthus B; Gliniak H; Szelag A; Mazurek W; Biały D; Maruszewski K
Biomed Mater; 2007 Dec; 2(4):220-3. PubMed ID: 18458478
[TBL] [Abstract][Full Text] [Related]
24. Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles.
Lu F; Wu SH; Hung Y; Mou CY
Small; 2009 Jun; 5(12):1408-13. PubMed ID: 19296554
[No Abstract] [Full Text] [Related]
25. Efficient internalization of mesoporous silica particles of different sizes by primary human macrophages without impairment of macrophage clearance of apoptotic or antibody-opsonized target cells.
Witasp E; Kupferschmidt N; Bengtsson L; Hultenby K; Smedman C; Paulie S; Garcia-Bennett AE; Fadeel B
Toxicol Appl Pharmacol; 2009 Sep; 239(3):306-19. PubMed ID: 19538981
[TBL] [Abstract][Full Text] [Related]
26. Size-dependent cytotoxic effects of amorphous silica nanoparticles on Langerhans cells.
Nabeshi H; Yoshikawa T; Matsuyama K; Nakazato Y; Arimori A; Isobe M; Tochigi S; Kondoh S; Hirai T; Akase T; Yamashita T; Yamashita K; Yoshida T; Nagano K; Abe Y; Yoshioka Y; Kamada H; Imazawa T; Itoh N; Tsunoda S; Tsutsumi Y
Pharmazie; 2010 Mar; 65(3):199-201. PubMed ID: 20383940
[TBL] [Abstract][Full Text] [Related]
27. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
Sant S; Poulin S; Hildgen P
J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249
[TBL] [Abstract][Full Text] [Related]
28. Proton absorption in as-synthesized mesoporous silica nanoparticles as a structure-function relationship probing mechanism.
Strømme M; Atluri R; Brohede U; Frenning G; Garcia-Bennett AE
Langmuir; 2009 Apr; 25(8):4306-10. PubMed ID: 19281159
[TBL] [Abstract][Full Text] [Related]
29. Lipid coated mesoporous silica nanoparticles as photosensitive drug carriers.
Yang Y; Song W; Wang A; Zhu P; Fei J; Li J
Phys Chem Chem Phys; 2010 May; 12(17):4418-22. PubMed ID: 20407714
[TBL] [Abstract][Full Text] [Related]
30. Biocompatibility of amorphous silica nanoparticles: Size and charge effect on vascular function, in vitro.
Akbar N; Mohamed T; Whitehead D; Azzawi M
Biotechnol Appl Biochem; 2011; 58(5):353-62. PubMed ID: 21995538
[TBL] [Abstract][Full Text] [Related]
31. Size effect of hydroxyapatite nanoparticles on proliferation and apoptosis of osteoblast-like cells.
Shi Z; Huang X; Cai Y; Tang R; Yang D
Acta Biomater; 2009 Jan; 5(1):338-45. PubMed ID: 18753024
[TBL] [Abstract][Full Text] [Related]
32. Mesoporous materials for drug delivery.
Vallet-Regí M; Balas F; Arcos D
Angew Chem Int Ed Engl; 2007; 46(40):7548-58. PubMed ID: 17854012
[TBL] [Abstract][Full Text] [Related]
33. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs.
Lu J; Liong M; Zink JI; Tamanoi F
Small; 2007 Aug; 3(8):1341-6. PubMed ID: 17566138
[No Abstract] [Full Text] [Related]
34. Submicrometer and nanoscale inorganic particles exploit the actin machinery to be propelled along microvilli-like structures into alveolar cells.
Orr G; Panther DJ; Phillips JL; Tarasevich BJ; Dohnalkova A; Hu D; Teeguarden JG; Pounds JG
ACS Nano; 2007 Dec; 1(5):463-75. PubMed ID: 19206668
[TBL] [Abstract][Full Text] [Related]
35. Skin penetration and cellular uptake of amorphous silica nanoparticles with variable size, surface functionalization, and colloidal stability.
Rancan F; Gao Q; Graf C; Troppens S; Hadam S; Hackbarth S; Kembuan C; Blume-Peytavi U; Rühl E; Lademann J; Vogt A
ACS Nano; 2012 Aug; 6(8):6829-42. PubMed ID: 22797484
[TBL] [Abstract][Full Text] [Related]
36. Intracellular degradation and distribution of protein-encapsulated amphiphilic poly(amino acid) nanoparticles.
Akagi T; Shima F; Akashi M
Biomaterials; 2011 Jul; 32(21):4959-67. PubMed ID: 21482432
[TBL] [Abstract][Full Text] [Related]
37. Cellular uptake, cytotoxicity, and innate immune response of silica-titania hollow nanoparticles based on size and surface functionality.
Oh WK; Kim S; Choi M; Kim C; Jeong YS; Cho BR; Hahn JS; Jang J
ACS Nano; 2010 Sep; 4(9):5301-13. PubMed ID: 20698555
[TBL] [Abstract][Full Text] [Related]
38. The influence of size and charge of chitosan/polyglutamic acid hollow spheres on cellular internalization, viability and blood compatibility.
Dash BC; Réthoré G; Monaghan M; Fitzgerald K; Gallagher W; Pandit A
Biomaterials; 2010 Nov; 31(32):8188-97. PubMed ID: 20701967
[TBL] [Abstract][Full Text] [Related]
39. Mannose-targeted mesoporous silica nanoparticles for photodynamic therapy.
Brevet D; Gary-Bobo M; Raehm L; Richeter S; Hocine O; Amro K; Loock B; Couleaud P; Frochot C; Morère A; Maillard P; Garcia M; Durand JO
Chem Commun (Camb); 2009 Mar; (12):1475-7. PubMed ID: 19277361
[TBL] [Abstract][Full Text] [Related]
40. Cellular level loading and heating of superparamagnetic iron oxide nanoparticles.
Kalambur VS; Longmire EK; Bischof JC
Langmuir; 2007 Nov; 23(24):12329-36. PubMed ID: 17960940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
